TY - JOUR
T1 - What hinders and helps in the end-of-life decision-making process for children
T2 - Parents’ and physicians’ views
AU - Zaal-Schuller, Ilse H.
AU - Geurtzen, Rosa
AU - Willems, Dick L.
AU - de Vos, Mirjam A.
AU - Hogeveen, Marije
N1 - Funding Information: In this manuscript, original transcripts from 4 interview studies were merged into one data set and then analysed. For two of these studies ( 16,17 ), funding from Fonds Nuts Ohra was received (grant number 1405‐135). Another study ( 18 ) was funded by the Rehabilitation Fund (het Revalidatiefonds) (grant number R2011131), the Fund for Intellectual Disabilities (het Fonds Verstandelijk Gehandicapten) (grant number L2011057) and the Erasmus Medical Centre, Department of Intellectual Disability Medicine (grant number SC200007). The fourth study did not receive any funding. The funds did not in any way influence the data acquisition, data analysis or drafting of this manuscript Publisher Copyright: © 2022 Foundation Acta Pædiatrica. Published by John Wiley & Sons Ltd.
PY - 2022/4
Y1 - 2022/4
N2 - Aim: To investigate the main factors which facilitate or hinder end-of-life decision-making (EoLDM) in neonates and children. Methods: A qualitative inductive, thematic analysis was performed of interviews with a total of 73 parents and 71 physicians. The end-of-life decisions mainly concern decisions to withhold or withdraw life-sustaining treatment. Results: The importance of taking sufficient time and exchanging clear, neutral and relevant information was main facilitators expressed by both parents and physicians. Lack of time, uncertain information and changing doctors were seen as important barriers by both parties. Most facilitators and barriers could be seen as two sides of the same coin, but not always. For example, some parents and physicians considered the fact that parents hold strong opinions as a barrier while others considered this a facilitator. Furthermore, parents and physicians showed differences. Parents especially underlined the importance of physician-related facilitators, such as a personalised approach, empathy and trust. On the contrary, physicians underlined the importance of the child's visible deterioration and parents’ awareness of the seriousness of their child's condition and prognosis as facilitators of EoLDM. Conclusions: This study gained insight into what parents and physicians experience as the main barriers and facilitators in EoLDM for neonates and children.
AB - Aim: To investigate the main factors which facilitate or hinder end-of-life decision-making (EoLDM) in neonates and children. Methods: A qualitative inductive, thematic analysis was performed of interviews with a total of 73 parents and 71 physicians. The end-of-life decisions mainly concern decisions to withhold or withdraw life-sustaining treatment. Results: The importance of taking sufficient time and exchanging clear, neutral and relevant information was main facilitators expressed by both parents and physicians. Lack of time, uncertain information and changing doctors were seen as important barriers by both parties. Most facilitators and barriers could be seen as two sides of the same coin, but not always. For example, some parents and physicians considered the fact that parents hold strong opinions as a barrier while others considered this a facilitator. Furthermore, parents and physicians showed differences. Parents especially underlined the importance of physician-related facilitators, such as a personalised approach, empathy and trust. On the contrary, physicians underlined the importance of the child's visible deterioration and parents’ awareness of the seriousness of their child's condition and prognosis as facilitators of EoLDM. Conclusions: This study gained insight into what parents and physicians experience as the main barriers and facilitators in EoLDM for neonates and children.
KW - communication
KW - decision-making
KW - end-of-life decisions
KW - ethics
KW - paediatrics
UR - http://www.scopus.com/inward/record.url?scp=85123889252&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/apa.16250
DO - https://doi.org/10.1111/apa.16250
M3 - Article
C2 - 35007341
SN - 0803-5253
VL - 111
SP - 873
EP - 887
JO - Acta paediatrica (Oslo, Norway
JF - Acta paediatrica (Oslo, Norway
IS - 4
ER -